← FDA Drug Approvals (Drugs@FDA)

ABELCET

NDA · New Drug Application · Sponsor: LEADIANT BIOSCI INC · Approved 1995-11-20

Drug application

FDA Application #

NDA050724

Application type

New Drug Application

Brand name

ABELCET

Generic name

Amphotericin B

Active ingredients

AMPHOTERICIN B

Dosage form

INJECTABLE, LIPID COMPLEX

Route

INJECTION

Marketing status

Discontinued

Sponsor

LEADIANT BIOSCI INC

First approval

1995-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown